Alliance Global Partners Maintains Buy on DarioHealth, Lowers Price Target to $4.1
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners analyst Ben Haynor maintains a 'Buy' rating on DarioHealth (NASDAQ:DRIO) but has lowered the price target from $5.45 to $4.1.
August 11, 2023 | 11:55 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DarioHealth's price target has been lowered from $5.45 to $4.1 by Alliance Global Partners, though the 'Buy' rating is maintained.
The lowering of the price target by Alliance Global Partners could potentially lead to a negative sentiment among investors, which may put downward pressure on DarioHealth's stock price in the short term. However, the maintained 'Buy' rating indicates that the analyst still sees potential in the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100